BIO generates very strong cashflows considering their growth rate is so high. I assume they can acheive this becuase of their 59% plus margins. It appears that other than some minor debt, their sales growth is effectively self funding. Very impressive quarterly result with an even more ecouraging outlook.
Ann: Quarterly Activities & Cashflow Report, page-8
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.0¢ |
Change
0.020(3.51%) |
Mkt cap ! $126.9M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 64.0¢ | 56.5¢ | $979.9K | 1.615M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6693 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 6000 | 1 |
View Market Depth
| Last trade - 15.47pm 03/07/2024 (20 minute delay) ? |
| BIO (ASX) Chart |